Paul Collinson, Leo Lam, John W. Pickering, Robert Christenson, Lieve Van Hoovels, Lena Jafri, Louise Cullen, Allan S. Jaffe, Fred S. Apple, Ola Hammarsten, Torbjørn Omland, Yader Sandoval, Nicholas L. Mills, Martin Than, Vanessa Buchan, Sverre Sandberg, Kristin M. Aakre
Implementing a bedside diagnostic device in a hospital setting presents a challenge. Particularly if it enables the ultrasensitive measurement of troponin and, consequently, the application of a rapid risk stratification algorithm in the management of patients suspected of acute coronary syndrome (ACS) in the emergency department This article, proposed by the expert group of the Committee on the Clinical Application of Cardiac Biomarkers of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC C-CB), offers recommendations and a practical framework for its implementation, covering all aspects (validation and verification of procedures, supplier responsibility, and on-site controls before routine use). This document is essential for all professionals involved in this process (suppliers, biologists, and emergency physicians) and for ensuring the success of this evolution in practice.